Bornaprine

beneficial effect in Parkinsonism due to inhibition of muscarinic or nicotinic transmission. It is grouped under the following drug class(es): Anticholinergics. Its therapeutic use is listed as antiparkinsonian agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Bornaprinum and bornaprina. Its PubChem CID is 70687267.

CAS No 20448-86-6
Molecular Formula C21H31NO2
Molecular Weight 329.5 g/mol
Synonyms 3-(diethylamino)propyl (1S,4R)-2-phenylbicyclo[2.2.1]heptane-2-carboxylate

Frequently Asked Questions